This study tests an experimental drug called RP1 that is injected directly into skin cancer tumors. The goal is to see if it can shrink or eliminate the cancer before surgery. Up to 12 adults with a type of skin cancer called cutaneous squamous cell carcinoma will take part. The …
Phase: PHASE1, PHASE2 • Sponsor: Sherrif Ibrahim • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC